,Tumor State,Gene Signature,MWU-BH p-value,MWU-BH-LOOCV p-value,GLM p-value,GLM-LOOCV p-value,Pseudobulk p-value,Pseudobulk-LOOCV p-value
1,Tumor State 1,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.4688,0.5135
2,Tumor State 1,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.4688,0.5246
3,Tumor State 1,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.4688,0.4905
4,Tumor State 1,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.4688,0.4983
5,Tumor State 1,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.4688,0.4905
6,Tumor State 1,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.4688,0.4905
7,Tumor State 1,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.4688,0.4905
8,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0267,0.0248,0.0,0.0,0.4688,0.4905
9,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.4688,0.4905
10,Tumor State 1,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.4688,0.4905
11,Tumor State 1,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.4688,0.4905
13,Tumor State 1,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.4688,0.4905
15,Tumor State 1,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.4688,0.4905
16,Tumor State 1,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.4688,0.4905
17,Tumor State 1,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.4688,0.4905
18,Tumor State 1,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.4688,0.4905
19,Tumor State 1,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.4688,0.5292
20,Tumor State 1,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0001,0.0,0.0,0.0,0.4688,0.5062
21,Tumor State 1,PAM50,0.0,0.0,0.0,0.0,0.4688,0.4905
22,Tumor State 1,WU_ET_AL_BASAL_SC,0.2549,0.2246,0.0066,0.0089,0.4688,0.4905
23,Tumor State 1,WU_ET_AL_HER2E_SC,0.0039,0.0023,0.2568,0.1601,0.4688,0.4905
24,Tumor State 1,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.4688,0.4905
25,Tumor State 1,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.4688,0.5425
26,Tumor State 1,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.4877,0.4868
27,Tumor State 1,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.4877,0.4868
28,Tumor State 1,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.4877,0.4868
29,Tumor State 1,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.4877,0.4793
30,Tumor State 1,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.4736,0.4759
31,Tumor State 1,HALLMARK_APICAL_SURFACE,0.0,0.0,0.0,0.0,0.4328,0.433
32,Tumor State 1,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.4877,0.4868
33,Tumor State 1,HALLMARK_BILE_ACID_METABOLISM,0.1508,0.1239,0.0427,0.0548,0.4877,0.4868
34,Tumor State 1,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0318,0.0367,0.0402,0.0475,0.4877,0.4868
35,Tumor State 1,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.4736,0.4555
36,Tumor State 1,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.4736,0.474
38,Tumor State 1,HALLMARK_E2F_TARGETS,0.0004,0.0008,0.0021,0.0029,0.4877,0.4839
39,Tumor State 1,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.4435,0.443
41,Tumor State 1,HALLMARK_ESTROGEN_RESPONSE_LATE,0.016,0.0231,0.0756,0.0908,0.4877,0.4868
42,Tumor State 1,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.4736,0.4747
43,Tumor State 1,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.4736,0.4656
44,Tumor State 1,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.4736,0.4842
45,Tumor State 1,HALLMARK_HEDGEHOG_SIGNALING,0.0,0.0,0.0,0.0001,0.4328,0.433
46,Tumor State 1,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.4328,0.433
47,Tumor State 1,HALLMARK_HYPOXIA,0.0001,0.0002,0.0,0.0,0.4736,0.4656
48,Tumor State 1,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.4877,0.4868
49,Tumor State 1,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.4571,0.4555
50,Tumor State 1,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.4435,0.4467
51,Tumor State 1,HALLMARK_KRAS_SIGNALING_DN,0.0006,0.0007,0.0,0.0,0.4877,0.4868
52,Tumor State 1,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.4545,0.4469
53,Tumor State 1,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.4328,0.433
54,Tumor State 1,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.4877,0.4868
55,Tumor State 1,HALLMARK_MYC_TARGETS_V1,0.0461,0.0626,0.0,0.0,0.4736,0.4847
57,Tumor State 1,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.4877,0.4793
59,Tumor State 1,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.4736,0.4665
60,Tumor State 1,HALLMARK_P53_PATHWAY,0.0,0.0,0.0001,0.0001,0.4877,0.4868
61,Tumor State 1,HALLMARK_PANCREAS_BETA_CELLS,0.0017,0.0016,0.0,0.0,0.4877,0.4868
62,Tumor State 1,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.4435,0.4428
63,Tumor State 1,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.4736,0.4656
65,Tumor State 1,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.4736,0.474
66,Tumor State 1,HALLMARK_SPERMATOGENESIS,0.0317,0.0289,0.044,0.0423,0.4877,0.4867
67,Tumor State 1,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.4571,0.45
68,Tumor State 1,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.4736,0.4665
69,Tumor State 1,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0001,0.0001,0.0001,0.0001,0.4877,0.4868
70,Tumor State 1,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.4328,0.433
73,Tumor State 1,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.4877,0.4868
74,Tumor State 1,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0001,0.0002,0.4328,0.433
75,Tumor State 1,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0001,0.0001,0.4877,0.4868
77,Tumor State 1,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4793
79,Tumor State 1,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
80,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0001,0.0003,0.4435,0.4469
81,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_UP,0.0,0.0,0.0002,0.0003,0.4736,0.4842
82,Tumor State 1,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
84,Tumor State 1,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4656
85,Tumor State 1,ONCOGENIC_ATM_DN.V1_UP,0.0,0.0001,0.0001,0.0002,0.4435,0.4417
86,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_DN,0.0094,0.0104,0.0973,0.1234,0.4435,0.433
87,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4867
89,Tumor State 1,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0323,0.0521,0.0004,0.0011,0.4736,0.4708
90,Tumor State 1,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0,0.0,0.0,0.4736,0.474
92,Tumor State 1,ONCOGENIC_BMI1_DN.V1_DN,0.0094,0.0081,0.0763,0.0716,0.4877,0.4868
93,Tumor State 1,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
94,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0003,0.0006,0.4877,0.4868
95,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
96,Tumor State 1,ONCOGENIC_BRCA1_DN.V1_DN,0.0,0.0,0.0,0.0,0.4545,0.4555
97,Tumor State 1,ONCOGENIC_BRCA1_DN.V1_UP,0.004,0.0031,0.0002,0.0002,0.4877,0.4868
98,Tumor State 1,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.4877,0.4868
99,Tumor State 1,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.4736,0.4555
100,Tumor State 1,ONCOGENIC_CAHOY_NEURONAL,0.0,0.0,0.0007,0.0007,0.4877,0.4868
101,Tumor State 1,ONCOGENIC_CAHOY_OLIGODENDROCUTIC,0.0033,0.0045,0.0031,0.0049,0.4435,0.433
102,Tumor State 1,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4746
104,Tumor State 1,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0145,0.0228,0.0115,0.0166,0.4571,0.4469
105,Tumor State 1,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4759
106,Tumor State 1,ONCOGENIC_CRX_DN.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.443
107,Tumor State 1,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0175,0.0232,0.0681,0.0898,0.4435,0.433
108,Tumor State 1,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
109,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.4545,0.4469
110,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.433
111,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
112,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0002,0.0002,0.4877,0.4868
114,Tumor State 1,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.0,0.0,0.4545,0.45
115,Tumor State 1,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
116,Tumor State 1,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4656
117,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4469
118,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4711
120,Tumor State 1,ONCOGENIC_DCA_UP.V1_UP,0.0,0.0,0.0,0.0,0.4571,0.4555
121,Tumor State 1,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
123,Tumor State 1,ONCOGENIC_E2F3_UP.V1_DN,0.0015,0.002,0.0039,0.0053,0.4571,0.4643
124,Tumor State 1,ONCOGENIC_E2F3_UP.V1_UP,0.0002,0.0001,0.0,0.0,0.4877,0.4868
125,Tumor State 1,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
126,Tumor State 1,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4847
127,Tumor State 1,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0,0.0,0.4545,0.45
129,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4417
130,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_UP,0.0043,0.0063,0.0062,0.009,0.4877,0.4867
131,Tumor State 1,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4469
132,Tumor State 1,ONCOGENIC_ESC_J1_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4842
133,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4428
134,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4842
135,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4417
137,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4656
138,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4772
139,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0001,0.0,0.0001,0.0,0.4736,0.4793
140,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0242,0.0402,0.107,0.1624,0.4435,0.4417
142,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.4428
144,Tumor State 1,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
145,Tumor State 1,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.4435,0.4467
146,Tumor State 1,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.4435,0.443
148,Tumor State 1,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
149,Tumor State 1,ONCOGENIC_IL15_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4793
150,Tumor State 1,ONCOGENIC_IL15_UP.V1_UP,0.0055,0.0038,0.0007,0.0005,0.4877,0.4868
151,Tumor State 1,ONCOGENIC_IL21_UP.V1_DN,0.0,0.0,0.0034,0.0037,0.4435,0.4507
152,Tumor State 1,ONCOGENIC_IL21_UP.V1_UP,0.0093,0.0134,0.0192,0.0237,0.4435,0.4417
153,Tumor State 1,ONCOGENIC_IL2_UP.V1_DN,0.0001,0.0001,0.0052,0.0045,0.4877,0.4842
154,Tumor State 1,ONCOGENIC_IL2_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.474
155,Tumor State 1,ONCOGENIC_JAK2_DN.V1_DN,0.0048,0.0041,0.0006,0.0007,0.4435,0.4417
156,Tumor State 1,ONCOGENIC_JAK2_DN.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.4428
157,Tumor State 1,ONCOGENIC_JNK_DN.V1_DN,0.0136,0.0175,0.0491,0.0641,0.4877,0.4868
158,Tumor State 1,ONCOGENIC_JNK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.481
159,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
160,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4809
161,Tumor State 1,ONCOGENIC_KRAS.50_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
163,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0371,0.049,0.0195,0.026,0.4877,0.4868
164,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
165,Tumor State 1,ONCOGENIC_KRAS.600_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
166,Tumor State 1,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4793
168,Tumor State 1,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0016,0.002,0.0313,0.0267,0.4877,0.4868
169,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0,0.0,0.0009,0.0008,0.4877,0.4868
170,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.4184,0.2468,0.0007,0.0011,0.4877,0.4842
171,Tumor State 1,ONCOGENIC_KRAS.DF.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4467
172,Tumor State 1,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.4469
173,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
174,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0378,0.0462,0.0023,0.0019,0.4877,0.4868
175,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.481
176,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4793
177,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0035,0.0028,0.0,0.0,0.4736,0.4842
178,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0,0.0,0.0,0.0,0.4545,0.4519
179,Tumor State 1,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
180,Tumor State 1,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.4571,0.4555
181,Tumor State 1,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
182,Tumor State 1,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
183,Tumor State 1,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4793
184,Tumor State 1,ONCOGENIC_LTE2_UP.V1_UP,0.0426,0.0454,0.0411,0.0383,0.4877,0.4847
185,Tumor State 1,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
186,Tumor State 1,ONCOGENIC_MEK_UP.V1_UP,0.0001,0.0001,0.0019,0.0012,0.4877,0.4867
187,Tumor State 1,ONCOGENIC_MEL18_DN.V1_DN,0.0007,0.0005,0.0017,0.0012,0.4877,0.4868
188,Tumor State 1,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
189,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
190,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
191,Tumor State 1,ONCOGENIC_MTOR_UP.V1_DN,0.0066,0.0077,0.016,0.0185,0.4545,0.4469
192,Tumor State 1,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
193,Tumor State 1,ONCOGENIC_MYC_UP.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4417
194,Tumor State 1,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
195,Tumor State 1,ONCOGENIC_NFE2L2.V2,0.0,0.0,0.0,0.0,0.4877,0.4867
196,Tumor State 1,ONCOGENIC_NOTCH_DN.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
197,Tumor State 1,ONCOGENIC_NOTCH_DN.V1_UP,0.0278,0.0415,0.1643,0.2146,0.4328,0.433
198,Tumor State 1,ONCOGENIC_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.443
200,Tumor State 1,ONCOGENIC_P53_DN.V1_DN,0.0004,0.0004,0.0,0.0,0.4736,0.4779
201,Tumor State 1,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
202,Tumor State 1,ONCOGENIC_P53_DN.V2_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
203,Tumor State 1,ONCOGENIC_P53_DN.V2_UP,0.0,0.0,0.0,0.0,0.4328,0.433
204,Tumor State 1,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4596
205,Tumor State 1,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.433
206,Tumor State 1,ONCOGENIC_PDGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4708
207,Tumor State 1,ONCOGENIC_PDGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
208,Tumor State 1,ONCOGENIC_PIGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4708
209,Tumor State 1,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
210,Tumor State 1,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
211,Tumor State 1,ONCOGENIC_PKCA_DN.V1_UP,0.0008,0.0011,0.0072,0.0077,0.4877,0.4868
213,Tumor State 1,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4793
214,Tumor State 1,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0,0.0,0.0,0.0,0.4545,0.45
216,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0011,0.0016,0.0122,0.0206,0.4545,0.4507
217,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0,0.0,0.0,0.0,0.4328,0.433
218,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0,0.0,0.0002,0.0002,0.4736,0.4779
219,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.0426,0.0452,0.0213,0.0234,0.4545,0.4555
220,Tumor State 1,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4842
223,Tumor State 1,ONCOGENIC_PTEN_DN.V2_UP,0.0,0.0,0.0,0.0,0.4435,0.4469
224,Tumor State 1,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
225,Tumor State 1,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0001,0.0,0.4877,0.4868
226,Tumor State 1,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4681
227,Tumor State 1,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0001,0.4736,0.47
228,Tumor State 1,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.4877,0.4842
229,Tumor State 1,ONCOGENIC_RB_DN.V1_UP,0.0,0.0,0.0,0.0,0.4877,0.4868
230,Tumor State 1,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4711
231,Tumor State 1,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4656
232,Tumor State 1,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.4736,0.4708
234,Tumor State 1,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0001,0.0001,0.4877,0.4868
235,Tumor State 1,ONCOGENIC_RELA_DN.V1_UP,0.0,0.0,0.0,0.0,0.4435,0.4469
237,Tumor State 1,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4793
238,Tumor State 1,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0287,0.0246,0.1034,0.0925,0.4877,0.4868
239,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.4736,0.4708
240,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_UP,0.004,0.0024,0.066,0.0561,0.4877,0.4868
241,Tumor State 1,ONCOGENIC_SNF5_DN.V1_DN,0.0322,0.0397,0.1095,0.1501,0.4736,0.4708
242,Tumor State 1,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4708
243,Tumor State 1,ONCOGENIC_SRC_UP.V1_DN,0.0006,0.0005,0.0105,0.0072,0.4877,0.4868
244,Tumor State 1,ONCOGENIC_SRC_UP.V1_UP,0.0005,0.0004,0.0004,0.0003,0.4877,0.4847
245,Tumor State 1,ONCOGENIC_STK33_DN,0.001,0.001,0.001,0.0013,0.4877,0.4868
246,Tumor State 1,ONCOGENIC_STK33_NOMO_DN,0.0,0.0,0.0,0.0,0.4877,0.4868
247,Tumor State 1,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.4435,0.433
248,Tumor State 1,ONCOGENIC_STK33_SKM_DN,0.0001,0.0001,0.0001,0.0001,0.4736,0.481
249,Tumor State 1,ONCOGENIC_STK33_SKM_UP,0.0,0.0,0.0,0.0,0.4736,0.4519
250,Tumor State 1,ONCOGENIC_STK33_UP,0.0,0.0,0.0,0.0,0.4435,0.4428
251,Tumor State 1,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.4328,0.433
252,Tumor State 1,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.4435,0.4428
253,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.4736,0.4759
254,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0001,0.0001,0.4877,0.4868
255,Tumor State 1,ONCOGENIC_TGFB_UP.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.4417
256,Tumor State 1,ONCOGENIC_TGFB_UP.V1_UP,0.0034,0.0045,0.0044,0.0044,0.4545,0.4408
257,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
258,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_UP,0.0,0.0,0.0,0.0,0.4736,0.4779
259,Tumor State 1,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.4435,0.45
261,Tumor State 1,ONCOGENIC_YAP1_DN,0.0,0.0,0.0,0.0,0.4328,0.433
1,Tumor State 2,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.2646,0.292
2,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.3595,0.3688
3,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.3508,0.3499
4,Tumor State 2,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.3508,0.3688
5,Tumor State 2,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.2438,0.2619
6,Tumor State 2,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.2438,0.2541
7,Tumor State 2,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.2438,0.2541
8,Tumor State 2,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.128,0.1146,0.0,0.0,0.3878,0.4349
9,Tumor State 2,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.2438,0.2649
10,Tumor State 2,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.2646,0.2735
11,Tumor State 2,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2438,0.2541
13,Tumor State 2,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.005,0.0152,0.0006,0.0023,0.3442,0.3661
15,Tumor State 2,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2438,0.2649
16,Tumor State 2,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2438,0.2541
17,Tumor State 2,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.2438,0.2541
18,Tumor State 2,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.2438,0.2541
19,Tumor State 2,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.3442,0.3473
20,Tumor State 2,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0012,0.0014,0.0062,0.0074,0.2646,0.2956
21,Tumor State 2,PAM50,0.0001,0.0001,0.0001,0.0001,0.3595,0.4015
22,Tumor State 2,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.5411,0.4873
23,Tumor State 2,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.3442,0.3688
25,Tumor State 2,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.5153,0.4859
26,Tumor State 2,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.5,0.4769
27,Tumor State 2,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.5,0.4769
28,Tumor State 2,HALLMARK_ANDROGEN_RESPONSE,0.0478,0.0125,0.9219,0.366,0.5,0.4769
29,Tumor State 2,HALLMARK_ANGIOGENESIS,0.0003,0.0011,0.0,0.0,0.5,0.4769
30,Tumor State 2,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.5,0.4769
31,Tumor State 2,HALLMARK_APICAL_SURFACE,0.0,0.0,0.0,0.0,0.5,0.4769
32,Tumor State 2,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.5,0.4769
33,Tumor State 2,HALLMARK_BILE_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.5,0.4769
34,Tumor State 2,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.5,0.4769
35,Tumor State 2,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.5,0.4769
36,Tumor State 2,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.5,0.4769
37,Tumor State 2,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.5,0.4769
38,Tumor State 2,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.5,0.4769
39,Tumor State 2,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.5,0.4769
40,Tumor State 2,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0012,0.0002,0.0038,0.0006,0.5,0.4769
42,Tumor State 2,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.5,0.4769
43,Tumor State 2,HALLMARK_G2M_CHECKPOINT,0.0003,0.0011,0.0007,0.0014,0.5,0.4769
44,Tumor State 2,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.5,0.4769
45,Tumor State 2,HALLMARK_HEDGEHOG_SIGNALING,0.0008,0.0006,0.0001,0.0001,0.5,0.4769
46,Tumor State 2,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.5,0.4769
47,Tumor State 2,HALLMARK_HYPOXIA,0.0002,0.0,0.105,0.034,0.5,0.4769
48,Tumor State 2,HALLMARK_IL2_STAT5_SIGNALING,0.0426,0.0266,0.3273,0.2273,0.5,0.4769
49,Tumor State 2,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.5,0.4769
50,Tumor State 2,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.5,0.4769
51,Tumor State 2,HALLMARK_KRAS_SIGNALING_DN,0.0021,0.0015,0.0079,0.0068,0.5,0.4769
52,Tumor State 2,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.5,0.4769
53,Tumor State 2,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.5,0.4769
54,Tumor State 2,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.5,0.4769
55,Tumor State 2,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0003,0.0002,0.5,0.4769
56,Tumor State 2,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0006,0.0004,0.5,0.4769
57,Tumor State 2,HALLMARK_MYOGENESIS,0.0074,0.006,0.0002,0.0002,0.5,0.4769
58,Tumor State 2,HALLMARK_NOTCH_SIGNALING,0.0,0.0,0.0,0.0001,0.5,0.4769
59,Tumor State 2,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.5,0.4769
60,Tumor State 2,HALLMARK_P53_PATHWAY,0.0236,0.0385,0.0093,0.0221,0.5,0.4769
61,Tumor State 2,HALLMARK_PANCREAS_BETA_CELLS,0.0,0.0,0.0,0.0,0.5,0.4769
62,Tumor State 2,HALLMARK_PEROXISOME,0.0024,0.0026,0.0037,0.0031,0.5,0.4769
63,Tumor State 2,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.5,0.4769
64,Tumor State 2,HALLMARK_PROTEIN_SECRETION,0.0006,0.0003,0.0015,0.0007,0.5,0.4769
65,Tumor State 2,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.5,0.4769
66,Tumor State 2,HALLMARK_SPERMATOGENESIS,0.0001,0.0002,0.0061,0.0089,0.5,0.4769
67,Tumor State 2,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.5,0.4769
68,Tumor State 2,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0001,0.0001,0.5,0.4769
69,Tumor State 2,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0025,0.0016,0.0,0.0,0.5,0.4769
70,Tumor State 2,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.5,0.4769
72,Tumor State 2,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0,0.0,0.0,0.0,0.5,0.4769
73,Tumor State 2,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0006,0.0002,0.5,0.4769
74,Tumor State 2,ONCOGENIC_AKT_UP.V1_DN,0.0003,0.0005,0.001,0.0021,0.5,0.4769
76,Tumor State 2,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
77,Tumor State 2,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0157,0.0131,0.0483,0.0379,0.5,0.4769
78,Tumor State 2,ONCOGENIC_ALK_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
79,Tumor State 2,ONCOGENIC_ALK_DN.V1_UP,0.0117,0.0063,0.0019,0.0006,0.5,0.4769
80,Tumor State 2,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
81,Tumor State 2,ONCOGENIC_ATF2_S_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
82,Tumor State 2,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
83,Tumor State 2,ONCOGENIC_ATF2_UP.V1_UP,0.0143,0.0143,0.0104,0.0103,0.5,0.4769
88,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0266,0.0057,0.0762,0.0178,0.5,0.4769
89,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0,0.0,0.0,0.0,0.5,0.4769
90,Tumor State 2,ONCOGENIC_BCAT_GDS748_DN,0.0036,0.0041,0.0266,0.0295,0.5,0.4769
92,Tumor State 2,ONCOGENIC_BMI1_DN.V1_DN,0.0012,0.0028,0.0001,0.0001,0.5,0.4769
93,Tumor State 2,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
94,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
95,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
96,Tumor State 2,ONCOGENIC_BRCA1_DN.V1_DN,0.0015,0.0021,0.0016,0.0027,0.5,0.4769
97,Tumor State 2,ONCOGENIC_BRCA1_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
98,Tumor State 2,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.5,0.4769
99,Tumor State 2,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.5,0.4769
101,Tumor State 2,ONCOGENIC_CAHOY_OLIGODENDROCUTIC,0.0209,0.0202,0.0956,0.0649,0.5,0.4769
102,Tumor State 2,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
103,Tumor State 2,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
104,Tumor State 2,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0794,0.1085,0.0374,0.0361,0.5,0.4769
105,Tumor State 2,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
106,Tumor State 2,ONCOGENIC_CRX_DN.V1_UP,0.0114,0.0128,0.0164,0.0206,0.5,0.4769
107,Tumor State 2,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
108,Tumor State 2,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
109,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
110,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0032,0.0031,0.0006,0.0006,0.5,0.4769
111,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
112,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
113,Tumor State 2,ONCOGENIC_CTIP_DN.V1_DN,0.0259,0.0184,0.0183,0.0132,0.5,0.4769
114,Tumor State 2,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
115,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
116,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0005,0.0001,0.0022,0.0006,0.5,0.4769
117,Tumor State 2,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
118,Tumor State 2,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0033,0.0021,0.0343,0.0235,0.5,0.4769
119,Tumor State 2,ONCOGENIC_DCA_UP.V1_DN,0.0041,0.0024,0.0021,0.001,0.5,0.4769
120,Tumor State 2,ONCOGENIC_DCA_UP.V1_UP,0.0841,0.0349,0.4404,0.189,0.5,0.4769
121,Tumor State 2,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
122,Tumor State 2,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
123,Tumor State 2,ONCOGENIC_E2F3_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
125,Tumor State 2,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
127,Tumor State 2,ONCOGENIC_EIF4E_DN,0.0408,0.0456,0.0171,0.0187,0.5,0.4769
128,Tumor State 2,ONCOGENIC_EIF4E_UP,0.0,0.0,0.0,0.0,0.5,0.4769
129,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
130,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_UP,0.0021,0.0003,0.001,0.0003,0.5,0.4769
131,Tumor State 2,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0066,0.0109,0.0117,0.0191,0.5,0.4769
133,Tumor State 2,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
135,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
136,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0057,0.0035,0.0341,0.0219,0.5,0.4769
137,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
138,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
139,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0008,0.0011,0.0004,0.0004,0.5,0.4769
140,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
141,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0003,0.0006,0.0035,0.0081,0.5,0.4769
142,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
143,Tumor State 2,ONCOGENIC_GLI1_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
144,Tumor State 2,ONCOGENIC_GLI1_UP.V1_UP,0.0182,0.02,0.0065,0.0064,0.5,0.4769
145,Tumor State 2,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.5,0.4769
146,Tumor State 2,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.5,0.4769
147,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
148,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
149,Tumor State 2,ONCOGENIC_IL15_UP.V1_DN,0.0001,0.0005,0.0018,0.0063,0.5,0.4769
150,Tumor State 2,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
151,Tumor State 2,ONCOGENIC_IL21_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
152,Tumor State 2,ONCOGENIC_IL21_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
153,Tumor State 2,ONCOGENIC_IL2_UP.V1_DN,0.0234,0.0254,0.0612,0.0598,0.5,0.4769
154,Tumor State 2,ONCOGENIC_IL2_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
155,Tumor State 2,ONCOGENIC_JAK2_DN.V1_DN,0.0007,0.0008,0.0031,0.0039,0.5,0.4769
156,Tumor State 2,ONCOGENIC_JAK2_DN.V1_UP,0.0,0.0001,0.0003,0.0005,0.5,0.4769
158,Tumor State 2,ONCOGENIC_JNK_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
159,Tumor State 2,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
160,Tumor State 2,ONCOGENIC_KRAS.300_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
161,Tumor State 2,ONCOGENIC_KRAS.50_UP.V1_DN,0.0132,0.0172,0.0004,0.0011,0.5,0.4769
164,Tumor State 2,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0209,0.0241,0.0025,0.0023,0.5,0.4769
165,Tumor State 2,ONCOGENIC_KRAS.600_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
166,Tumor State 2,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
167,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0006,0.0003,0.0002,0.0001,0.5,0.4769
168,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
169,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
170,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
172,Tumor State 2,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
175,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0209,0.0229,0.0006,0.0004,0.5,0.4769
176,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.002,0.0037,0.0,0.0,0.5,0.4769
177,Tumor State 2,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
178,Tumor State 2,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0863,0.0374,0.4603,0.4469,0.5,0.4769
179,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0012,0.0003,0.0009,0.0002,0.5,0.4769
180,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0988,0.0473,0.0969,0.06,0.5,0.4769
181,Tumor State 2,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
182,Tumor State 2,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
183,Tumor State 2,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
184,Tumor State 2,ONCOGENIC_LTE2_UP.V1_UP,0.0014,0.0007,0.002,0.0009,0.5,0.4769
185,Tumor State 2,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
186,Tumor State 2,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
187,Tumor State 2,ONCOGENIC_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
188,Tumor State 2,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
189,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
190,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
192,Tumor State 2,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
194,Tumor State 2,ONCOGENIC_MYC_UP.V1_UP,0.0039,0.0038,0.0023,0.0026,0.5,0.4769
195,Tumor State 2,ONCOGENIC_NFE2L2.V2,0.0,0.0,0.0,0.0,0.5,0.4769
196,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_DN,0.0005,0.0005,0.0003,0.0003,0.5,0.4769
197,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
198,Tumor State 2,ONCOGENIC_NRL_DN.V1_DN,0.0117,0.0052,0.1211,0.071,0.5,0.4769
199,Tumor State 2,ONCOGENIC_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
200,Tumor State 2,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
201,Tumor State 2,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
203,Tumor State 2,ONCOGENIC_P53_DN.V2_UP,0.0,0.0001,0.0,0.0,0.5,0.4769
204,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
205,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0078,0.01,0.0164,0.0207,0.5,0.4769
206,Tumor State 2,ONCOGENIC_PDGF_UP.V1_DN,0.0417,0.0536,0.1415,0.1846,0.5,0.4769
207,Tumor State 2,ONCOGENIC_PDGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
208,Tumor State 2,ONCOGENIC_PIGF_UP.V1_DN,0.0144,0.008,0.0193,0.0127,0.5,0.4769
209,Tumor State 2,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
210,Tumor State 2,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
212,Tumor State 2,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.0008,0.0015,0.0091,0.0152,0.5,0.4769
214,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
215,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0001,0.0002,0.0015,0.0025,0.5,0.4769
216,Tumor State 2,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0191,0.0159,0.0012,0.0008,0.5,0.4769
217,Tumor State 2,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0001,0.0002,0.0002,0.0005,0.5,0.4769
218,Tumor State 2,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
219,Tumor State 2,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.0179,0.0198,0.0103,0.0118,0.5,0.4769
220,Tumor State 2,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
221,Tumor State 2,ONCOGENIC_PTEN_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
222,Tumor State 2,ONCOGENIC_PTEN_DN.V2_DN,0.0,0.0,0.0,0.0,0.5,0.4769
223,Tumor State 2,ONCOGENIC_PTEN_DN.V2_UP,0.0,0.0,0.0,0.0,0.5,0.4769
224,Tumor State 2,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
225,Tumor State 2,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
226,Tumor State 2,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
227,Tumor State 2,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
228,Tumor State 2,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
230,Tumor State 2,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
231,Tumor State 2,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
232,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
233,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
234,Tumor State 2,ONCOGENIC_RELA_DN.V1_DN,0.0142,0.0129,0.0018,0.0029,0.5,0.4769
236,Tumor State 2,ONCOGENIC_RPS14_DN.V1_DN,0.0024,0.0011,0.0003,0.0002,0.5,0.4769
237,Tumor State 2,ONCOGENIC_RPS14_DN.V1_UP,0.0073,0.0138,0.0017,0.003,0.5,0.4769
238,Tumor State 2,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0,0.0,0.5,0.4769
239,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.5,0.4769
240,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.5,0.4769
241,Tumor State 2,ONCOGENIC_SNF5_DN.V1_DN,0.0098,0.0087,0.0043,0.0032,0.5,0.4769
242,Tumor State 2,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
243,Tumor State 2,ONCOGENIC_SRC_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
244,Tumor State 2,ONCOGENIC_SRC_UP.V1_UP,0.0332,0.0137,0.0509,0.0192,0.5,0.4769
245,Tumor State 2,ONCOGENIC_STK33_DN,0.0,0.0,0.0,0.0,0.5,0.4769
246,Tumor State 2,ONCOGENIC_STK33_NOMO_DN,0.0,0.0,0.0,0.0,0.5,0.4769
247,Tumor State 2,ONCOGENIC_STK33_NOMO_UP,0.0192,0.0353,0.0064,0.01,0.5,0.4769
248,Tumor State 2,ONCOGENIC_STK33_SKM_DN,0.0,0.0,0.0,0.0,0.5,0.4769
249,Tumor State 2,ONCOGENIC_STK33_SKM_UP,0.0649,0.0257,0.2748,0.0955,0.5,0.4769
251,Tumor State 2,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.5,0.4769
252,Tumor State 2,ONCOGENIC_TBK1.DF_UP,0.0351,0.0399,0.0057,0.007,0.5,0.4769
253,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0002,0.0002,0.5,0.4769
254,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.5,0.4769
255,Tumor State 2,ONCOGENIC_TGFB_UP.V1_DN,0.0042,0.004,0.0524,0.0488,0.5,0.4769
256,Tumor State 2,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
257,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
258,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
259,Tumor State 2,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.5,0.4769
260,Tumor State 2,ONCOGENIC_WNT_UP.V1_UP,0.0144,0.0092,0.011,0.0086,0.5,0.4769
261,Tumor State 2,ONCOGENIC_YAP1_DN,0.0058,0.0066,0.0272,0.0293,0.5,0.4769
262,Tumor State 2,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.5,0.4769
1,Tumor State 3,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0001,0.0008,0.0018,0.0116,0.5652,0.4368
2,Tumor State 3,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0001,0.5652,0.4368
3,Tumor State 3,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0012,0.0453,0.0011,0.0394,0.5652,0.4368
4,Tumor State 3,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.5652,0.4368
5,Tumor State 3,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0001,0.0007,0.001,0.0052,0.5652,0.4368
6,Tumor State 3,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0003,0.0007,0.5652,0.4368
7,Tumor State 3,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.5652,0.4368
8,Tumor State 3,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0,0.0,0.0,0.0,0.5652,0.4368
9,Tumor State 3,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.5652,0.4368
10,Tumor State 3,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0034,0.0154,0.1575,0.1332,0.5652,0.4368
11,Tumor State 3,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0001,0.5652,0.4368
13,Tumor State 3,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0002,0.5652,0.4368
15,Tumor State 3,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0002,0.5652,0.4368
16,Tumor State 3,WP_TYPE_III_INTERFERON_SIGNALING,0.0031,0.0166,0.0931,0.2009,0.5652,0.4368
17,Tumor State 3,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0007,0.001,0.5652,0.4368
18,Tumor State 3,ZHANG_INTERFERON_RESPONSE,0.0008,0.0006,0.0141,0.0047,0.5652,0.4368
19,Tumor State 3,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0014,0.0,0.0002,0.5652,0.4368
22,Tumor State 3,WU_ET_AL_BASAL_SC,0.0001,0.004,0.0001,0.002,0.5652,0.4368
23,Tumor State 3,WU_ET_AL_HER2E_SC,0.0713,0.027,0.0804,0.017,0.5652,0.4368
24,Tumor State 3,WU_ET_AL_LUMA_SC,0.0059,0.0046,0.0002,0.0005,0.5652,0.4368
25,Tumor State 3,WU_EL_AL_LUMB_SC,0.158,0.0161,0.1114,0.0094,0.5652,0.4368
26,Tumor State 3,HALLMARK_ADIPOGENESIS,0.0268,0.0331,0.0106,0.0107,0.5,0.3864
27,Tumor State 3,HALLMARK_ALLOGRAFT_REJECTION,0.0006,0.006,0.0025,0.0151,0.5,0.3864
28,Tumor State 3,HALLMARK_ANDROGEN_RESPONSE,0.0115,0.0341,0.0013,0.0203,0.5,0.3864
29,Tumor State 3,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.5,0.3864
30,Tumor State 3,HALLMARK_APICAL_JUNCTION,0.0007,0.0036,0.0003,0.0012,0.5,0.3864
32,Tumor State 3,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.5,0.3864
33,Tumor State 3,HALLMARK_BILE_ACID_METABOLISM,0.0144,0.0296,0.0037,0.0167,0.5,0.3864
34,Tumor State 3,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0036,0.0108,0.0012,0.0048,0.5,0.3864
35,Tumor State 3,HALLMARK_COAGULATION,0.0,0.0001,0.0,0.0,0.5,0.3864
36,Tumor State 3,HALLMARK_COMPLEMENT,0.0008,0.0155,0.0008,0.0153,0.5,0.3864
37,Tumor State 3,HALLMARK_DNA_REPAIR,0.0426,0.1374,0.1171,0.3138,0.5,0.3864
38,Tumor State 3,HALLMARK_E2F_TARGETS,0.001,0.0021,0.0959,0.1784,0.5,0.3864
39,Tumor State 3,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.5,0.3864
40,Tumor State 3,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0644,0.1425,0.0425,0.109,0.5,0.3864
43,Tumor State 3,HALLMARK_G2M_CHECKPOINT,0.001,0.0023,0.0384,0.0782,0.5,0.3864
44,Tumor State 3,HALLMARK_GLYCOLYSIS,0.0045,0.012,0.0012,0.0022,0.5,0.3864
46,Tumor State 3,HALLMARK_HEME_METABOLISM,0.0,0.0002,0.0,0.0,0.5,0.3864
47,Tumor State 3,HALLMARK_HYPOXIA,0.0022,0.0082,0.0,0.0012,0.5,0.3864
48,Tumor State 3,HALLMARK_IL2_STAT5_SIGNALING,0.0145,0.0174,0.0155,0.0207,0.5,0.3864
49,Tumor State 3,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0014,0.0009,0.0008,0.0005,0.5,0.3864
50,Tumor State 3,HALLMARK_INFLAMMATORY_RESPONSE,0.0001,0.0001,0.0,0.0001,0.5,0.3864
53,Tumor State 3,HALLMARK_MITOTIC_SPINDLE,0.0,0.0009,0.0,0.0,0.5,0.3864
54,Tumor State 3,HALLMARK_MTORC1_SIGNALING,0.0,0.0001,0.0,0.0,0.5,0.3864
55,Tumor State 3,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0001,0.5,0.3864
57,Tumor State 3,HALLMARK_MYOGENESIS,0.0003,0.0005,0.0001,0.0001,0.5,0.3864
58,Tumor State 3,HALLMARK_NOTCH_SIGNALING,0.2059,0.2322,0.0306,0.0529,0.5,0.3864
59,Tumor State 3,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.5,0.3864
62,Tumor State 3,HALLMARK_PEROXISOME,0.0615,0.0795,0.0418,0.0549,0.5,0.3864
63,Tumor State 3,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0006,0.0001,0.0009,0.5,0.3864
64,Tumor State 3,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.5,0.3864
65,Tumor State 3,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0009,0.0077,0.0018,0.0206,0.5,0.3864
67,Tumor State 3,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0001,0.0,0.0,0.5,0.3864
68,Tumor State 3,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0001,0.0001,0.0,0.0,0.5,0.3864
69,Tumor State 3,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.5,0.3864
70,Tumor State 3,HALLMARK_UV_RESPONSE_DN,0.0062,0.0185,0.0059,0.0127,0.5,0.3864
71,Tumor State 3,HALLMARK_UV_RESPONSE_UP,0.0115,0.0078,0.0022,0.002,0.5,0.3864
80,Tumor State 3,ONCOGENIC_ATF2_S_UP.V1_DN,0.0168,0.0583,0.0139,0.0493,0.5,0.3864
81,Tumor State 3,ONCOGENIC_ATF2_S_UP.V1_UP,0.0511,0.0962,0.0111,0.0305,0.5,0.3864
82,Tumor State 3,ONCOGENIC_ATF2_UP.V1_DN,0.1054,0.2196,0.0333,0.1292,0.5,0.3864
89,Tumor State 3,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0003,0.0019,0.0002,0.0009,0.5,0.3864
93,Tumor State 3,ONCOGENIC_BMI1_DN.V1_UP,0.0021,0.0198,0.0009,0.0079,0.5,0.3864
95,Tumor State 3,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0511,0.1141,0.0228,0.045,0.5,0.3864
97,Tumor State 3,ONCOGENIC_BRCA1_DN.V1_UP,0.0726,0.2576,0.0498,0.2312,0.5,0.3864
99,Tumor State 3,ONCOGENIC_CAHOY_ASTROGLIAL,0.0006,0.0007,0.0003,0.0003,0.5,0.3864
102,Tumor State 3,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0001,0.0,0.0,0.5,0.3864
103,Tumor State 3,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.3864
105,Tumor State 3,ONCOGENIC_CRX_DN.V1_DN,0.0059,0.0098,0.0021,0.0029,0.5,0.3864
108,Tumor State 3,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0059,0.0269,0.0016,0.0137,0.5,0.3864
110,Tumor State 3,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0038,0.0095,0.0026,0.0066,0.5,0.3864
112,Tumor State 3,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0473,0.099,0.2181,0.325,0.5,0.3864
114,Tumor State 3,ONCOGENIC_CTIP_DN.V1_UP,0.2032,0.1335,0.0481,0.0449,0.5,0.3864
115,Tumor State 3,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0009,0.0021,0.0003,0.0011,0.5,0.3864
116,Tumor State 3,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0511,0.0465,0.018,0.0219,0.5,0.3864
117,Tumor State 3,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0453,0.0283,0.0172,0.0097,0.5,0.3864
121,Tumor State 3,ONCOGENIC_E2F1_UP.V1_DN,0.004,0.0028,0.0013,0.0012,0.5,0.3864
123,Tumor State 3,ONCOGENIC_E2F3_UP.V1_DN,0.1303,0.1245,0.0266,0.0279,0.5,0.3864
124,Tumor State 3,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0004,0.0,0.0001,0.5,0.3864
127,Tumor State 3,ONCOGENIC_EIF4E_DN,0.0088,0.029,0.0008,0.0038,0.5,0.3864
129,Tumor State 3,ONCOGENIC_ERBB2_UP.V1_DN,0.0181,0.0224,0.0133,0.0184,0.5,0.3864
134,Tumor State 3,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0813,0.0424,0.0219,0.0152,0.5,0.3864
135,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.5,0.3864
136,Tumor State 3,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0235,0.036,0.038,0.0606,0.5,0.3864
141,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0425,0.0739,0.0123,0.0376,0.5,0.3864
142,Tumor State 3,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0031,0.0223,0.0151,0.056,0.5,0.3864
144,Tumor State 3,ONCOGENIC_GLI1_UP.V1_UP,0.0153,0.0354,0.0214,0.0282,0.5,0.3864
146,Tumor State 3,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.5,0.3864
148,Tumor State 3,ONCOGENIC_HOXA9_DN.V1_UP,0.0055,0.0958,0.0024,0.0694,0.5,0.3864
160,Tumor State 3,ONCOGENIC_KRAS.300_UP.V1_UP,0.01,0.0704,0.0919,0.3125,0.5,0.3864
163,Tumor State 3,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0336,0.081,0.0797,0.2538,0.5,0.3864
164,Tumor State 3,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0054,0.0369,0.0212,0.0914,0.5,0.3864
166,Tumor State 3,ONCOGENIC_KRAS.600_UP.V1_UP,0.001,0.0239,0.0203,0.1294,0.5,0.3864
168,Tumor State 3,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0252,0.063,0.2709,0.3572,0.5,0.3864
171,Tumor State 3,ONCOGENIC_KRAS.DF.V1_DN,0.0153,0.0156,0.0112,0.0101,0.5,0.3864
179,Tumor State 3,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.414,0.2526,0.0257,0.1123,0.5,0.3864
180,Tumor State 3,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0025,0.013,0.0047,0.0244,0.5,0.3864
182,Tumor State 3,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.5,0.3864
183,Tumor State 3,ONCOGENIC_LTE2_UP.V1_DN,0.0088,0.0032,0.0047,0.003,0.5,0.3864
184,Tumor State 3,ONCOGENIC_LTE2_UP.V1_UP,0.0208,0.0406,0.0007,0.0024,0.5,0.3864
187,Tumor State 3,ONCOGENIC_MEL18_DN.V1_DN,0.022,0.0476,0.011,0.0178,0.5,0.3864
188,Tumor State 3,ONCOGENIC_MEL18_DN.V1_UP,0.0145,0.0141,0.0022,0.0039,0.5,0.3864
193,Tumor State 3,ONCOGENIC_MYC_UP.V1_DN,0.0268,0.0198,0.0315,0.0313,0.5,0.3864
194,Tumor State 3,ONCOGENIC_MYC_UP.V1_UP,0.0153,0.0763,0.0025,0.0271,0.5,0.3864
195,Tumor State 3,ONCOGENIC_NFE2L2.V2,0.0106,0.0787,0.002,0.0218,0.5,0.3864
196,Tumor State 3,ONCOGENIC_NOTCH_DN.V1_DN,0.0009,0.0044,0.0003,0.0019,0.5,0.3864
198,Tumor State 3,ONCOGENIC_NRL_DN.V1_DN,0.0399,0.0546,0.0367,0.0542,0.5,0.3864
200,Tumor State 3,ONCOGENIC_P53_DN.V1_DN,0.0301,0.06,0.0226,0.0642,0.5,0.3864
203,Tumor State 3,ONCOGENIC_P53_DN.V2_UP,0.0764,0.149,0.0195,0.0371,0.5,0.3864
205,Tumor State 3,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0007,0.0057,0.0002,0.0009,0.5,0.3864
209,Tumor State 3,ONCOGENIC_PIGF_UP.V1_UP,0.0002,0.0119,0.0001,0.0023,0.5,0.3864
211,Tumor State 3,ONCOGENIC_PKCA_DN.V1_UP,0.0003,0.0023,0.0004,0.0014,0.5,0.3864
212,Tumor State 3,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.0004,0.0031,0.0002,0.0028,0.5,0.3864
221,Tumor State 3,ONCOGENIC_PTEN_DN.V1_UP,0.0367,0.1227,0.0072,0.03,0.5,0.3864
228,Tumor State 3,ONCOGENIC_RB_DN.V1_DN,0.0035,0.0044,0.0013,0.0023,0.5,0.3864
230,Tumor State 3,ONCOGENIC_RB_P107_DN.V1_DN,0.0268,0.0653,0.0328,0.0579,0.5,0.3864
232,Tumor State 3,ONCOGENIC_RB_P130_DN.V1_DN,0.0004,0.0052,0.0001,0.0018,0.5,0.3864
237,Tumor State 3,ONCOGENIC_RPS14_DN.V1_UP,0.0392,0.0703,0.0171,0.0431,0.5,0.3864
238,Tumor State 3,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0001,0.0005,0.0003,0.0029,0.5,0.3864
239,Tumor State 3,ONCOGENIC_SIRNA_EIF4GI_DN,0.0268,0.0773,0.0345,0.0846,0.5,0.3864
240,Tumor State 3,ONCOGENIC_SIRNA_EIF4GI_UP,0.0099,0.0075,0.0069,0.0064,0.5,0.3864
242,Tumor State 3,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.5,0.3864
245,Tumor State 3,ONCOGENIC_STK33_DN,0.0145,0.0486,0.0025,0.0075,0.5,0.3864
246,Tumor State 3,ONCOGENIC_STK33_NOMO_DN,0.0001,0.0029,0.0001,0.001,0.5,0.3864
247,Tumor State 3,ONCOGENIC_STK33_NOMO_UP,0.0054,0.0247,0.0022,0.0089,0.5,0.3864
251,Tumor State 3,ONCOGENIC_TBK1.DF_DN,0.0004,0.002,0.0001,0.0001,0.5,0.3864
254,Tumor State 3,ONCOGENIC_TBK1.DN.48HRS_UP,0.0065,0.0199,0.0007,0.0024,0.5,0.3864
255,Tumor State 3,ONCOGENIC_TGFB_UP.V1_DN,0.0599,0.0835,0.0267,0.0341,0.5,0.3864
256,Tumor State 3,ONCOGENIC_TGFB_UP.V1_UP,0.0099,0.0115,0.0061,0.0084,0.5,0.3864
257,Tumor State 3,ONCOGENIC_VEGF_A_UP.V1_DN,0.0007,0.0033,0.0005,0.0018,0.5,0.3864
261,Tumor State 3,ONCOGENIC_YAP1_DN,0.037,0.0644,0.0637,0.1132,0.5,0.3864
